Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor.

The human lympholine osteoclast activating factor (OAF) is thought to be involved in several bone-destroying diseases. The current studies were designed to produce monoclonal antibodies against OAF for use in the subsequent design of immunoassays for OAF in clinical samples. Spleen cells from mice i...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	J Clin Invest
Principais autores:	Luben, R A, Mohler, M A, Nedwin, G E
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Clinical Investigation 1979
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372124/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/221547/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109459
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!